Matricelf Ltd (TLV:MTLF)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
227.10
-8.00 (-3.40%)
Apr 28, 2026, 5:24 PM IDT
-26.03%
Market Cap 66.41M
Revenue (ttm) n/a
Net Income (ttm) -27.86M
Shares Out 29.24M
EPS (ttm) -1.51
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 596,553
Average Volume 109,321
Open 241.00
Previous Close 235.10
Day's Range 212.00 - 241.60
52-Week Range 204.00 - 853.00
Beta 0.57
RSI 17.67
Earnings Date May 1, 2026

About Matricelf

Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company’s regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson’s disease, and myocardial infarction, as well as for 3D bioprinting. The company has a strategic collaboration with Sheba Medical Center for the development and clinical advancement of its neural tissue implant product for the treatment of spinal cord inju... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2019
Employees 15
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol MTLF
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.